Mixed Review: Combine Your Checks and Plan Your Next Study Cycle

Introduction

Real pharmacy work rarely tests one skill at a time. A single prescription can depend on three things: knowing exactly what product it is, noticing a safety problem, and doing the math correctly. Each check can fail without the others failing. A perfect calculation does not help if it is done for the wrong product.

This lesson practices all three checks together. It also shows how to explain why a believable wrong answer is wrong, and how to use your mistakes to plan what to study next. Getting answers right in this guide is useful practice. It is not proof that you are ready for the exam.

What You Will Be Able to Do

• Work through one case using an identity check, a safety check and an arithmetic check, in that order.
• Explain why a plausible wrong answer fails by naming the fact it ignores.
• Tell a federal rule apart from a state requirement, and recognizing a problem apart from making a clinical decision.
• Sort your errors into types and build a targeted next study cycle.

Before you start: This lesson combines skills taught elsewhere. If a step feels unfamiliar, review Read a medicine identity before learning a name, Metric conversions and dimensional analysis, Recognize when the pharmacist must intervene and Controlled-substance schedules and valid orders. All cases here are fictional. Their numbers are set up for practice and are not treatment instructions.

Three Checks and One Question About Who Decides

Use the same three checks on every case:

1. Identity: what exactly is this product? Look at the active ingredient or ingredients, the strength, the dosage form (tablet, liquid, suppository and so on) and whether the release is regular or extended. Two products can share an ingredient and still be different products.
2. Safety: is there anything a pharmacist must review? The PTCE content outline lists issues that require pharmacist intervention. They include drug utilization review (DUR, a check of a medicine against the patient's other medicines and conditions), adverse drug events, OTC recommendations, therapeutic substitution, allergies and drug interactions.
3. Arithmetic: do the numbers and units work? Check the dose, quantity, concentration and units. Then check that the answer is a reasonable size.

Then ask one more question: who decides? A technician's job is to recognize a problem and bring it to the pharmacist. Deciding whether a treatment is appropriate is a clinical decision. PTCB also notes that each state's Board of Pharmacy defines a technician's legal scope of practice. So "what may a technician do here?" can have a different answer in different states.

Worked Case: One Patient, Two Acetaminophen Products

Fictional case. An adult patient brings in a new prescription for a combination tablet. The label lists acetaminophen 325 mg per tablet plus a second active ingredient. The directions are: 1 tablet every 6 hours as needed, no more than 4 tablets in 24 hours, for 7 days. While waiting, the patient mentions also taking an over-the-counter (OTC) pain reliever. They take 2 caplets three times a day, and the OTC label lists acetaminophen 500 mg per caplet.

Step 1: Identity. Read the ingredient lists, not just the product names. Acetaminophen appears in hundreds of OTC and prescription products. It can be the only active ingredient or one of several. Prescription labels may abbreviate it as APAP or a shortened spelling such as "Acetam." Outside the US it is commonly called paracetamol. Here, both products contain acetaminophen.

Step 2: Safety. FDA advises against using more than one acetaminophen-containing product at a time, because it is easy to take too much without realizing it. FDA also warns that too much acetaminophen can cause liver failure and death. Two products with the same ingredient is a duplication finding, and that is a pharmacist issue.

Step 3: Arithmetic. Calculate the most acetaminophen the patient could take in a day:

• Prescription maximum: 4 tablets × 325 mg = 1,300 mg
• OTC use as described: 2 caplets × 3 times = 6 caplets × 500 mg = 3,000 mg
• Combined: 1,300 mg + 3,000 mg = 4,300 mg in 24 hours

FDA's consumer page states that adults and children 12 and older should not take more than 4,000 mg of acetaminophen in 24 hours. Each product's own label still governs its directions. The combined amount is above that general maximum.

Quantity check for the prescription: 4 tablets per day × 7 days = 28 tablets at most. Check by reversing it: 28 ÷ 7 = 4 per day ✓.

Who decides? The technician brings the duplication and the calculated total to the pharmacist. The technician does not tell the patient to stop either product. That is a clinical judgment.

Why the tempting answer fails

A believable wrong answer is: "The prescription is correct and the quantity of 28 is right, so fill it."

The only part of that answer that has been verified is the arithmetic: 28 tablets matches the prescription's maximum of 4 tablets per day for 7 days. That does not establish that the prescription itself is correct. The second active ingredient has not been identified, and the pharmacist's review is still pending. The answer also ignores the OTC product the patient mentioned. Correct arithmetic shows that the numbers are internally consistent. It does not show that the therapy is safe for this patient, and it does not authorize dispensing.

Changed case: the total is lower

Now change one fact. The patient takes the OTC product only as 2 caplets once a day: 2 × 500 = 1,000 mg. The combined maximum is now 1,300 + 1,000 = 2,300 mg, which is below 4,000 mg.

Does that clear the problem? No. The duplication finding comes from two acetaminophen products being used at once, not only from the total. The lower number is useful information for the pharmacist. It is not a technician's reason to skip the referral.

Changed case: no shared ingredient

Change a different fact. The OTC label lists no acetaminophen. The acetaminophen-duplication finding disappears, because the shared ingredient was its cause. That does not mean "nothing to review." Whether the patient should combine an OTC product with a new prescription is still an OTC-recommendation and interaction question for the pharmacist. Review Duplication, interactions and contraindications if that distinction is unclear.

Question 1

Fictional case: an adult's prescription label lists a combination tablet with "APAP 500 mg" per tablet, 1 tablet every 8 hours, maximum 3 tablets per day. The patient has no other medicines on file and mentions none. A coworker says, "The total is only 1,500 mg a day, so the acetaminophen limit can't be an issue." Which of the three checks has actually been completed, and what does the coworker's reasoning assume?

Same Ingredient Does Not Mean Same Product

The worked case relied on a shared ingredient. The opposite mistake is just as common: assuming that a shared ingredient makes two products interchangeable.

FDA lists acetaminophen in several forms: tablets (including extended-release and chewable), capsules, liquids, powders and rectal suppositories. FDA has also warned about confusion caused by liquid acetaminophen products with different concentrations. A concentration is how much drug is contained in a stated volume, such as "mg per 5 mL."

Worked arithmetic: the volume depends on the concentration

Fictional order: a dose of 240 mg of acetaminophen. Product A's label (fictional): 160 mg per 5 mL.

Set it up so that the units cancel:

240 mg × (5 mL ÷ 160 mg) = 1,200 ÷ 160 = 7.5 mL

Check: 160 mg in 5 mL is 32 mg per mL, and 7.5 mL × 32 mg/mL = 240 mg ✓.

Change only the product. Product B's label (fictional) says 100 mg per 1 mL. The correct volume is 240 mg × (1 mL ÷ 100 mg) = 2.4 mL. If someone reused the 7.5 mL from Product A, the patient would get 7.5 × 100 = 750 mg. That is more than three times the intended dose, from the same ingredient and the same volume.

This is why FDA tells caregivers to use the dosing device that comes with the product, not a device from a different product. A device marked for one concentration can be wrong for another.

The same logic applies to release type. Regular-release and extended-release tablets with the same ingredient are different formulations, designed to release the drug differently. Switching one for the other changes what was ordered, and the pharmacist must review it.

Question 2

Fictional case: a pharmacy is out of the liquid acetaminophen product named on an order. A technician finds another liquid acetaminophen product on the shelf and plans to use the same number of mL listed in the directions, "since it's the same drug." Explain what must be checked and why the plan fails.

Decimal and Unit Traps

Some arithmetic errors come from how a number is written, not from the calculation.

• Leading zero: always write a zero before a decimal point for numbers less than one. NIST recommends this so that the quantity is read correctly. FDA describes ".5 mg" being misread as "5 mg," which is a tenfold overdose.
• Trailing zero: do not add a zero after a whole number. FDA describes "5.0 mg" being misread as "50 mg," which is also tenfold.
• Unit prefixes: a prefix changes the size of a unit. Milli- means one-thousandth (10⁻³). Micro- means one-millionth (10⁻⁶). So 1 mg = 1,000 mcg. FDA notes that misreading "mcg" or "µg" as "mg" creates a 1,000-fold overdose.
• "U" for units: FDA reports deaths from tenfold insulin overdoses when a handwritten "U" was misread as a zero. For example, "1U" was read as "10."

A magnitude check catches many of these errors. After converting, ask whether the new number should be larger or smaller. Converting mg to mcg moves to a smaller unit, so the number must get larger.

Question 3

Fictional case: an order is written as "0.25 mg." Convert it to micrograms. Then explain what would happen if a reader saw "mcg" where "mg" was meant, and why a leading zero matters here.

Rules Have a Scope: Federal and State Together

Correct arithmetic is not the only thing that can seem to settle a case. A federal rule can seem to settle it too. Federal requirements apply nationwide. State requirements are set by each state and can add conditions. A federal rule that permits something does not show that every state permits it.

Worked case: transferring an electronic controlled-substance prescription

Fictional case. A patient's prescriber sent an electronic prescription for a Schedule IV controlled substance to Pharmacy 1. It has authorized refills, has never been filled and has never previously been transferred. The patient asks to have it filled at Pharmacy 2, another retail pharmacy.

Under the federal rule in 21 CFR 1306.08, a transfer for initial dispensing of an electronic Schedule II–V prescription between retail pharmacies is allowed only if all of these conditions are met:

• The patient requests it.
• It happens on a one-time basis only.
• The prescription moves in its electronic form. No intermediary may convert it to another form, such as a fax.
• Its required contents are not altered. Any change, including truncation or removal of data, makes it invalid.
• The transfer is communicated directly between two licensed pharmacists.
• It is allowable under existing state or other applicable law.

For a Schedule III, IV or V prescription, authorized refills transfer along with it. Both pharmacies must keep the electronic transfer records for two years.

In this case, the patient asked, it is a first transfer, and the drug is Schedule IV. The federal conditions can be met if the pharmacists carry it out correctly. But the federal rule itself says the transfer is permitted only if state law allows it, so the state requirement still has to be checked.

Why the tempting answers fail

• "Federal law allows it, so it's allowed." This ignores the rule's own state-law condition.
• "A technician at Pharmacy 1 can phone a technician at Pharmacy 2." The federal text requires communication directly between two licensed pharmacists. Whatever a state lets technicians do in other tasks, it cannot remove this federal requirement.
• "Print it and fax it over to save time." Converting the prescription to another form is prohibited.

Changed case: a second transfer

Change one fact. The prescription was already transferred once for initial dispensing, and it is still unfilled. Now the patient wants it moved again. The federal rule allows this transfer one time only. A second transfer fails a federal condition, so no state permission can satisfy it. Both sets of rules must be met; meeting one does not cancel the other. For more on transfers, see Refills, partial fills and transfers.

Question 4

Fictional case: during an otherwise correct electronic transfer of an unfilled Schedule III prescription, the receiving system cuts off part of the prescriber's information. A coworker says, "The drug and directions came through fine, so it's still usable." Explain why this answer fails.

How to Explain Why a Wrong Answer Fails

Each worked case used the same three-part method. Use it on any question you miss, or on any answer choice you are unsure about.

1. Name the true fact the wrong answer relies on. Plausible wrong answers usually contain one, such as "the quantity is 28" or "federal law permits transfers."
2. Name the fact it ignores or stretches. For example: "a second acetaminophen product," "a different concentration," or "the state-law condition."
3. State the change that would make it right. If the OTC product had no acetaminophen, the duplication finding would disappear. If it were the first transfer and state law allowed it, the transfer could proceed.

Step 3 confirms that you understand the rule well enough to predict a new case, not just recognize the example you studied.

Independent Practice

Use the three checks and the three-part method. There is no new teaching in this section.

Question 5

A recall notice for a fictional tablet lists the product name, strength, package size and lot numbers 4471 and 4472. It is labeled a Class III recall. Your pharmacy has the same product, strength and size from lot 4472. A coworker says, "Class III means it's not likely to cause harm, so keep using it until it runs out." What is wrong with this reasoning, and what should happen?

Question 6

A handwritten fictional order reads "Give 5.0 mg." Another reads "Give .5 mg." For each one, state what the intended dose most likely was, what it could be misread as, and the size of the error.

Question 7

A patient who has used acetaminophen for years without problems comes back saying a rash started after they began a new acetaminophen-containing product. They ask, "Is this from the acetaminophen? It can't be, I've taken it forever." Which response is best, and why do the other two fail?

• A) "It can't be acetaminophen, since you've taken it safely before."
• B) "Yes, the acetaminophen caused it."
• C) Bring in the pharmacist right away to talk with the patient.

Question 8

Fictional case: an adult has a prescription for an acetaminophen-containing combination tablet, 650 mg of acetaminophen per dose, 1 dose every 6 hours, for 5 days. Calculate the maximum acetaminophen per day from this prescription, and the number of doses for the full course. Then state what the arithmetic does and does not tell you.

Turn Your Errors Into a Next Study Cycle

Missed questions are information. A study cycle is a repeated loop: practice, diagnose, relearn the specific gap, then practice on new items.

Step 1: Log every miss and every guess

For each item, record what you chose, what was correct, and how sure you were. Count a correct guess as an error. A lucky answer shows nothing about what you understand.

Step 2: Classify the cause

Most errors fall into one of these types:

• Identity: you misread an ingredient, strength, form, release type or concentration.
• Safety recognition: you did the task correctly but missed something the pharmacist needed to see.
• Arithmetic and units: you used the wrong setup, made a prefix or decimal error, or skipped the magnitude check.
• Rule scope: you applied a rule outside its conditions, or treated a federal rule as the whole answer.
• Reading: you skipped a word that changed the answer, such as "per 5 mL," "one-time" or "lot."

Step 3: Choose one or two targets

Pick the error type that appears most often. Use the PTCE content outline (effective January 6, 2026) to decide how much a gap matters. Its four domains are weighted as follows:

• Medications: 35%
• Patient Safety and Quality Assurance: 23.75%
• Order Entry and Processing: 22.50%
• Federal Requirements: 18.75%

These weights describe the exam's content, not your personal gaps. A small domain where you miss most items can still deserve your next study block.

Step 4: Relearn the distinguishing fact, then practice on new items

Go back to the relevant lesson and look for the one fact that separates the right answer from your answer. Then practice on new items with different wording. If you redo the same questions, you may simply remember the answers. Later, retest on fresh mixed items to see whether the fix holds.

Worked example of a study plan

A learner's log from this lesson shows these results:

• Correct on Question 8 (arithmetic), but marked as a guess on the "every 6 hours" step.
• Missed Question 4 by accepting the truncated transfer.
• Missed Question 2 by reusing the same mL volume.

Classification: one arithmetic guess (Sig interpretation), one rule-scope error, and one identity error (concentration).

Next cycle: first, review Concentrations, ratios and dilutions and Read a medicine identity before learning a name. Concentration falls under Medications, the most heavily weighted domain, and it caused a dangerous-size error. Second, review Refills, partial fills and transfers with a focus on the conditions that make a transfer invalid. Third, practice frequency abbreviations in Read the prescription and translate the directions. Then take a new mixed set and check whether these error types appear again.

What this guide cannot tell you

The PTCE is a computer-based exam with 90 multiple-choice questions. 80 are scored and 10 are unscored. Results are reported as scaled scores from 1,000 to 1,600, and 1,400 is the passing score. Your percentage correct in this guide does not convert to a scaled score. This guide's exercises are not PTCE questions. The guide is not affiliated with PTCB, and it makes no claim to be a PTCB-Recognized Education/Training Program.

PTCE eligibility has its own requirements, such as completing a PTCB-recognized program or at least 500 hours of equivalent work experience. Completing this guide does not satisfy them. PTCB offers its own practice tools, the PTCE Practice Bank and the Pre-PTCE, and its content outline is the reference for what the exam covers.

Question 9

A learner takes a separate ten-item practice set and scores 9 out of 10, and two of the correct answers were guesses. They decide: "I'm basically ready. I'll redo these same questions until I get 10 out of 10." Identify two problems with this plan and propose a better next step.

Summary

• Check identity, safety and arithmetic on every case, then ask who decides. Technicians recognize and refer; pharmacists make clinical judgments; and states define a technician's legal scope.
• Same ingredient does not mean same product. Check the concentration, form and release type. The same volume of a different concentration is a different dose.
• Correct arithmetic does not authorize dispensing. It shows the numbers are consistent, not that the therapy is appropriate.
• Write numbers safely: use a leading zero, never a trailing zero, and keep mg and mcg distinct.
• Federal permission is not the whole answer. The federal electronic-transfer rule itself requires state permission, and its own conditions (one time only, between licensed pharmacists, unaltered electronic form) still apply.
• Explain wrong answers in three parts: the true fact the answer uses, the fact it ignores, and the change that would make it right.
• Study in cycles: log misses and guesses, classify them, target one or two types, relearn, practice on new items and retest. Practice scores here do not show exam readiness.